Ultragenyx Pharmaceutical... (RARE)
NASDAQ: RARE
· Real-Time Price · USD
29.07
1.25 (4.49%)
At close: Sep 26, 2025, 3:12 PM
Ultragenyx Pharmaceutical Revenue
Ultragenyx Pharmaceutical reported an annual revenue of $560.23M, reflecting a 29.01% growth. For the quarter ending June 30, 2025, Ultragenyx Pharmaceutical generated $166.5M in revenue.
Revenue (ttm)
560.23M
Revenue Growth
29.01%
Price / Sales Ratio
6.8
Revenue / Employee
432.94K
Employees
1,294
Market Cap
2.8B
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 560.23M | +29.01% |
| Dec 31, 2023 | 434.25M | +19.52% |
| Dec 31, 2022 | 363.33M | +3.39% |
| Dec 31, 2021 | 351.41M | +29.66% |
| Dec 31, 2020 | 271.03M | +161.32% |
| Dec 31, 2019 | 103.71M | +101.41% |
| Dec 31, 2018 | 51.49M | +1871.48% |
| Dec 31, 2017 | 2.61M | +1863.91% |
| Dec 31, 2016 | 133K | +Infinity% |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |
| Dec 31, 2011 | 0 | n/a |